Negative Impacts of COVID-19 Induced Lockdown on Changes in Eating Behavior, Physical Activity, and Mental Health as Modified by Digital Healthy Diet Literacy and eHealth Literacy

Nguyen, Tham T.; Nguyen, Minh H.; Pham, Thu Trang; Le, Vinh-Tuyen T.; Nguyen, Tan Tien; Luong, Thuc C.; Binh, N.; Dao, Hung K.; Nguyen, Huu C.; Ha, Tung H.; Pham, Linh; Nguyen, Phuoc B.; Nguyen, Hoai Than; Thinh, V.; Nguyen, Hung Q.; Trinh, Manh V.; Le, Thuy; Tra, Anh L.; Nguyen, Thao Thanh; Nguyen, Kien Trung; Phan, Dung T.; Pham, Khue M.; Bai, Chyi‐Huey; Duong, Tuyen Van

doi:10.3389/fnut.2021.774328

Cited by 17 publications

(7 citation statements)

References 58 publications

(78 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For example, a recent study found that physical activities have declined among Vietnamese patients who comply with restrictions on outside activities to minimize COVID-19 exposure. 49 Other previous studies also found that COVID-19 has harmful impacts on physical activities and exercise; these studies indicated that 40% of the general population have physical inactivity due to fear of exposing COVID-19. 50 , 51 Thus, as the COVID-19 pandemic continues its infection and deadly path, dramatic changes in behaviors should be examined to embrace medication adherence behaviors to prevent complications among patients with chronic disease.…”

Section: Discussionmentioning

confidence: 86%

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review

et al. 2022

View full text Add to dashboard Cite

Objective To determine how the COVID-19 pandemic impacts patients with chronic disease medication adherence. Methods Four electronic databases, PubMed, MEDLINE, Web of Science, and CINAHL Plus Full Text, were searched for literature between 2019 and 2021. Abstracts and later full texts were independently screened by the authors of this review using inclusion and exclusion criteria to determine relevance to our study. Joanna Briggs Institute (JBI) critical appraisal tools were used to assess the quality of included texts. Relevant information and data from the included texts were extracted into tables for data synthesis and analysis. Results Ten studies met the study criteria, the most popular study design was cross-sectional design (n = 9, 90.0%), others were case series (n = 1, 10.0%). Barriers to medication adherence and facilitators of medication adherence were the major two themes that participants reported regarding the impact of COVID-19 on medication adherence. Moreover, these two main themes have been organized in sub-themes that are dealt with in-depth. Discussion Our results could heighten healthcare providers, stakeholders, and policy leaders’ awareness of providing appropriate support for chronic disease patients, especially regarding medication adherence. Future research incorporating programs that support patients’ needs is recommended.

show abstract

Section: Discussionmentioning

confidence: 86%

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Most effective public health measures to prevent depressive symptoms, anxiety and sleep disorders are behavioral such as practicing a regular physical activity, ( 48 , 49 ) and having social interaction. Both were particularly limited during the first lockdown ( 50 – 52 ). Therefore, despite the fear of the COVID-19 itself, the lockdown and its associated behavioral restriction might have increase prevent depressive symptoms, anxiety, and sleep disorders.…”

Section: Discussionmentioning

confidence: 99%

Effect of the COVID-19 pandemic on the psychotropic drug consumption

Benistand

Vorilhon²,

Laporte³

et al. 2022

Front. Psychiatry

View full text Add to dashboard Cite

ImportanceAlthough the COVID-19 pandemic has had a negative impact on mental health, there is no comprehensive longitudinal study of the entire population of a country without selection bias.ObjectiveThe objective of this study was to evaluate the prescription of psychotropic drugs during the COVID-19 pandemic, using data from the French national health data system (SNDS).Design, settings, and participantsPrescriptions for psychotropic drugs (antidepressants, anxiolytics, hypnotics, and antipsychotics) from 1 January 2015 to 30 September 2021 were collected from administrative data provided by the SNDS. This database includes more than 99% of the French population, i.e., 67 million people. The data were analyzed using an interrupted time series analysis (ITSA) model.Main outcomes and measuresConsumption of psychotropic drugs was aggregated in months and expressed in number of boxes per thousand inhabitants.ResultsDuring the study period, more than 1.3 billion boxes of psychotropic medications were dispensed. Comparison of psychotropic drug dispensing before and after the pandemic showed a relative increase of 0.76 (95 CI 0.57 to 0.95, p<0.001) boxes per month per thousand inhabitants, all classes of psychotropic drugs combined. Three classes saw their consumption increase in an almost similar proportion, respectively, by 0.23 (0.15 to 0.32, p<0.001) boxes for antidepressants, 0.27 (0.20 to 0.34, p<0.001) boxes for anxiolytics and 0.23 (0.17 to 0.30, p<0.001) boxes for hypnotics. The change in antipsychotic consumption was very small, with an increase of 0.04 boxes (0.02 to 0.06, p = 0.001) per month per thousand population.Conclusion and relevanceThe COVID-19 pandemic had led to an increase in the consumption of psychotropic drugs, confirming the significant impact of the pandemic on the mental health of the general population.

show abstract

“…In this study, socio-demographics, comorbidity, physical activity, health literacy, and digital health literacy were also included and treated as covariates, which showed associations with mental health in previous studies [26,43].…”

Section: Covariatesmentioning

confidence: 99%

The Associations of Suspected COVID-19 Symptoms with Anxiety and Depression as Modified by Hemodialysis Dietary Knowledge: A Multi-Dialysis Center Study

et al. 2022

Self Cite

View full text Add to dashboard Cite

During the COVID-19 pandemic, it is essential to evaluate hemodialysis patients’ dietary knowledge, especially among those with COVID-19 related symptoms, in order to identify appropriate strategies in managing their mental health. The study’s purposes were to test the psychometric properties of the hemodialysis dietary knowledge (HDK) scale, and to investigate the modifying impact of HDK on the associations of suspected COVID-19 symptoms (S-COVID-19-S) with anxiety and depression among hemodialysis patients. A cross-sectional study was conducted from July 2020 to March 2021 at eight hospitals across Vietnam. Data of 875 hemodialysis patients were analyzed, including socio-demographic, anxiety (the generalized anxiety disorder scale, GAD-7), depression (the patient health questionnaire, PHQ-9), S-COVID-19-S, HDK, health literacy, and digital healthy diet literacy. Confirmatory factor analysis (CFA) and logistic regression models were used to analyze the data. The HDK scale demonstrates the satisfactory construct validity with good model fit (Goodness of Fit Index, GFI = 0.96; Adjusted Goodness of Fit Index, AGFI = 0.90; Standardized Root Mean Square Residual, SRMR = 0.05; Root Mean Square Error of Approximation, RMSEA = 0.09; Normed Fit Index, NFI = 0.96; Comparative Fit Index, CFI = 0.96, and Parsimony goodness of Fit Index, PGFI = 0.43), criterion validity (as correlated with HL (r = 0.22, p < 0.01) and DDL (r = 0.19, p < 0.01), and reliability (Cronbach alpha = 0.70)). In the multivariate analysis, S-COVID-19-S was associated with a higher likelihood of anxiety (odds ratio, OR, 20.76; 95% confidence interval, 95%CI, 8.85, 48.70; p < 0.001) and depression (OR, 12.95; 95%CI, 6.67, 25.14, p < 0.001). A higher HDK score was associated with a lower likelihood of anxiety (OR, 0.70; 95%CI, 0.64, 0.77; p < 0.001) and depression (OR, 0.72; 95%CI, 0.66, 0.79; p < 0.001). In the interaction analysis, the negative impacts of S-COVID-19-S on anxiety and depression were mitigated by higher HDK scores (p < 0.001). In conclusion, HDK is a valid and reliable tool to measure dietary knowledge in hemodialysis patients. Higher HDK scores potentially protect patients with S-COVID-19-S from anxiety and depression during the pandemic.

show abstract

Negative Impacts of COVID-19 Induced Lockdown on Changes in Eating Behavior, Physical Activity, and Mental Health as Modified by Digital Healthy Diet Literacy and eHealth Literacy

Cited by 17 publications

References 58 publications

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review

How does the COVID-19 pandemic impact medication adherence of patients with chronic disease?: A systematic review

Effect of the COVID-19 pandemic on the psychotropic drug consumption

The Associations of Suspected COVID-19 Symptoms with Anxiety and Depression as Modified by Hemodialysis Dietary Knowledge: A Multi-Dialysis Center Study

Contact Info

Product

Resources

About